Comparative Trial of Home-Based Palliative Care
追踪信息 | |||
---|---|---|---|
首次提交日期 ICMJE | September 27, 2018 | ||
首次发布日期e ICMJE | October 3, 2018 | ||
最后更新发布日期 | October 3, 2018 | ||
预计研究开始日期 ICMJE | January 2019 | ||
预计主要完成日期 | September 2022 (主要结果测量的最终数据收集日期) | ||
目前主要观察指标 ICMJE |
Symptom severity (total score) using the Edmonton Symptom Assessment Scale (ESAS)[ Time Frame: Change from baseline to 1 month ] The ESAS is a 10-item survey measuring symptom severity. Scores range from 0-100 with higher scores indicating worse symptoms. Days at home in the last 180 days of life among patients surviving at least 180 days after enrolling in HBPC[ Time Frame: Baseline to 12 months ] Caregiver preparedness for caregiving using the Preparedness for Caregiving Scale[ Time Frame: Change from baseline to 1 month ] The Preparedness for Caregiving Scale is a 9-item survey measuring caregivers' perception of their preparedness for caregiving. Scores range from 0-36 with higher scores indicating higher perception of preparedness |
||
原始主要观察测量 ICMJE | 与当前相同 | ||
目前的二级观察 ICMJE |
|
||
描述性信息 | |||
简略标题 ICMJE | Comparative Trial of Home-Based Palliative Care | ||
正式标题 ICMJE | A Non-Inferiority Comparative Effectiveness Trial of Home-Based Palliative Care in Older Adults | ||
简要概况 | Background: To effectively alleviate suffering and improve quality of life for patients with serious illness and their caregivers, palliative care (PC) services must be offered across multiple settings. Research is needed to determine how best to optimize home-based palliative care (HBPC) services to meet the needs of individuals with high symptom burden and functional limitations. Aim: The investigators will compare a standard HBPC model that includes routine home visits by a nurse and provider with a more efficient tech-supported HBPC model that promotes timely inter-professional team coordination via synchronous video consultation with the provider while the nurse is in the patient's home. The investigators hypothesize that tech-supported HBPC will be as effective as standard HBPC. Design: Cluster randomized trial. Registered nurses (n~130) will be randomly assigned to the tech-supported or standard HBPC model so that half of the patient-caregiver dyads will receive one of the two models. Setting/Participants: Kaiser Permanente (15 Southern California and Oregon sites). Patients (n=10,000) with any serious illness and a prognosis of 1-2 years and their caregivers (n=4,800) Methods: Patients and caregivers will receive standard PC services: comprehensive needs assessment and care planning, pain and symptom management, education/skills training, medication management, emotional/spiritual support; care coordination, referral to other services, and 24/7 phone assistance. Results: Primary patient outcomes: symptom improvement at 1 month and days spent at home in the last six months of life; caregiver outcome: perception of preparedness for caregiving. Conclusion: Should the more efficient tech-supported HBPC model achieves comparable improvements in outcomes that matter most to patients and caregivers, this would have a lasting impact on PC practice and policy. |
||
详细说明 | |||
研究类型 ICMJE | Interventional | ||
研究阶段 | N/A | ||
研究设计 ICMJE | 分配: Randomized 干预模型: Parallel Assignment 干预模型描述: Randomization of registered nurses stratified by site (n=15) to either standard or tech-supported HBPC 盲法: Interventional 盲法描述: 主要目的: Supportive Care |
||
适用条件 ICMJE | |||
干预项目 ICMJE |
|
||
研究工具 |
|
||
招募信息 | |||
招募状态 ICMJE | Not yet recruiting | ||
预计入组 ICMJE |
14800 | ||
原始预计入组 ICMJE | 与当前相同 | ||
预计研究完成日期 | September 2022 | ||
预计主要完成日期 | September 2022 (主要结果测量的最终数据收集日期) | ||
合格标准 ICMJE | Patient Inclusion Criteria: - Serious illness with 12-24 month life expectancy - Homebound - Need for skilled nursing care (only at KP Southern California) - English or Spanish speakers Patient Exclusion Criteria: - Currently receiving HBPC Caregiver Inclusion Criteria: - Non-professional family, friend or other caregiver - English or Spanish speakers | ||
性别 |
|
||
年龄 | 最小年龄:18 Years ,最大年龄:N/A | ||
接受健康的志愿者 | 没有 | ||
可入组国家 ICMJE | |||
管理信息 | 数据检测委员会 | Yes | |
研究涉及美国FDA监管的产品 |
研究美国FDA监管的药品: No 研究涉及美国FDA监管的设备产品: No |
||
IPD 共享声明 |
|
||
责任方 | , | ||
研究赞助商 ICMJE | Kaiser Permanente | ||
合作者 ICMJE | |||
研究员 ICMJE |
|
||
PRS 账户 | |||
验证日期 | October 2018 | ||
ICMJE 国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素 |